Comments on: QALSODY™ (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause

Comments on: QALSODY™ (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause https://lifeboat.com/blog/2025/05/qalsody-tofersen-injection-receives-conditional-marketing-authorization-from-health-canada-as-the-first-als-treatment-targeting-a-genetic-cause Safeguarding Humanity Wed, 07 May 2025 06:06:48 +0000 hourly 1 https://wordpress.org/?v=6.8.1